Institut Für Klinische Krebsforschung Ikf Gmbh At Krankenhaus Nordwest
Clinical trials sponsored by Institut Für Klinische Krebsforschung Ikf Gmbh At Krankenhaus Nordwest, explained in plain language.
-
New hope: drug before surgery may stop merkel cell cancer spread
Disease control Not yet recruitingThis study tests whether giving the drug cemiplimab before lymph node surgery can prevent Merkel cell carcinoma from spreading to nearby lymph nodes. About 135 adults with early-stage cancer will receive either the drug or a placebo before their scheduled biopsy. The goal is to s…
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Jun 17, 2026 03:27 UTC
-
Double immune attack: new combo therapy targets tough lymphoma
Disease control Not yet recruitingThis phase 2 trial tests a new treatment strategy for people with a fast-growing blood cancer (large B-cell lymphoma) that has come back or not responded to standard therapy. The approach uses two immune-based treatments: a drug called glofitamab given before and after standard C…
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New Pre-Surgery combo aims to boost cancer fight in stomach and esophageal tumors
Disease control Not yet recruitingThis study tests giving a combination of chemotherapy (FLOT) and an immunotherapy drug (durvalumab) before surgery, followed by more durvalumab after surgery, for people with stomach or esophageal cancer that can be removed. The goal is to see if this approach leads to a complete…
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC